Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Enveric Biosciences Inc (ENVB) vs Novavax Inc (NVAX) Price & Performance

Enveric Biosciences IncTrade
Novavax IncTrade

Price performance (Past 24H)

Key statistics

Enveric Biosciences Inc vs Novavax Inc — how do they compare? Enveric Biosciences Inc trades at $1.45 (market cap $6.20M), while Novavax Inc trades at $7.96 (market cap $1.31B). The key difference: Novavax Inc is far larger — about 211.3× Enveric Biosciences Inc's market cap, and Novavax Inc is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.

ENVBNVAX
Market Cap
$6.20M$1.31B
Sector
HealthHealth
52-Week High
$17.40$11.19
52-Week Low
$1.27$6.22
Enterprise Value
$1.30M$889.30M

Returns comparison

Trailing returns across standard periods

About Enveric Biosciences Inc

Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.

Read more on ENVB

About Novavax Inc

Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.

Read more on NVAX